Prulifloxacin

It is a thiazeto-quinoline derivative and is a lipophilic prodrug of ulifloxacin, orally effective antibacterial agent.

Indications

In the treatment of urinary tract (acute uncomplicated and complicated) and respiratory tract infections AECB.

Dosage

600mg as a single dose in the treatment of acute uncomplicated lower UTIs, and as a once-daily 600mg dosage for a maximum of 10 days in the treatment of complicated lower UTIs.

Contra-Indications

Hypersensitivity. Pregnancy and lactation. Children or adolescents below 18 yr with uncomplicated skeletal development. History of tendon diseases related to administration of quinolones.

Side Effects

Blood dyscrasias; CNS disorders; Gastrointestinal disorders; Urticaria (occasional).